[Pathology due to Klebsiella].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000941:Antigens / Q000032:analysis; D001996:Bronchopneumonia / Q000382:microbiology / Q000473:pathology; D004352:Drug Resistance, Microbial; D004653:Empyema / Q000382:microbiology / Q000473:pathology; D004751:Enteritis / Q000382:microbiology / Q000473:pathology; D006801:Humans; D007709:Klebsiella / Q000145:classification / Q000276:immunology / Q000472:pathogenicity*; D007710:Klebsiella Infections / Q000188:drug therapy / Q000473:pathology*; D008581:Meningitis / Q000382:microbiology; D009268:Nalidixic Acid / Q000627:therapeutic use; D011014:Pneumonia / Q000382:microbiology / Q000473:pathology; D018805:Sepsis / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology / Q000473:pathology
D000900:Anti-Bacterial Agents; D000941:Antigens; D009268:Nalidixic Acid
Patologia da klebsielle.